1 We describe 10 straightforward writing tips-and a web tool, P
2 We describe 2 cases of renal lymphangiectasia in transplanted
3 We describe 47 patients referred to our hospital between 21 F
4 We describe a Bayesian hierarchical model, called Bayesian In
5 ate the synthesis of paromomycin and/or neomycin analogues,
we describe a cleavage of ring I from paromomycin that procee
6 Here,
we describe a function for NEK10 in the regulation of p53 tra
7 We describe a lethal combined nervous and reproductive system
8 Here,
we describe a mechanism by which the innate immune system all
9 Here
we describe a method for isolating human gut-associated lymph
10 In this study,
we describe a new approach for preparing islets that enhances
11 Here,
we describe a new fossil specimen from Drimolen Main Quarry,
12 In this study,
we describe a novel high throughput, micro-macro approach for
13 Here
we describe a platform for efficient Cas12a gene editing in D
14 Here
we describe a platform for the detection of IgG anti-drug ant
15 Here,
we describe a rare case of highly efficient near-cognate init
16 Here
we describe a robust genetic program that intrinsically atten
17 We describe a specific example of a gAP in humans linked to i
18 We describe a strategy performed in Brazil to enable and acce
19 We described a detailed SAR in TLR2 agonistic scaffolds and a
20 Here,
we described a new, comprehensive system of in silico methods
21 Previously,
we described a strategy to rapidly identify and generate llam
22 In this study,
we describe an active poultry surveillance system established
23 Here
we describe an ex vivo cultured human skin explant model in w
24 Here,
we describe an optimization strategy for reducing scrambling
25 Here
we describe an ultrasensitive form of polymerization-based re
26 Herein,
we describe bacterial metabolites with known or suspected neu
27 sence of heterogeneous spatial sequences of metal ions that
we describe,
depending on the metal and synthesis temperature
28 In this Perspective,
we describe efforts to decipher heterogeneity in T2D and deta
29 Herein,
we describe how a biomimetic synthesis of bruceol, a pentacyc
30 lariopsis cylindrus and Pseudo-nitzschia multistriata Here,
we describe how functional genomics and reverse genetics have
31 We describe invasive MRSA trends by strain type.
32 Herein,
we describe light-responsive tethers, containing an azobenzen
33 We describe our design, synthesis, and chemical study of a se
34 In addition,
we describe research pipelines that broaden evidence-based ap
35 of the BBSome by itself and in complex with ARL6(GTP), and
we describe the changes in BBSome conformation induced by ARL
36 In this retrospective cohort study,
we describe the clinical presentation and workup of parathyro
37 Herein,
we describe the design and performance of an integrated micro
38 Here,
we describe the development and use of an assay to monitor th
39 Herein,
we describe the discovery and optimization of a class of pote
40 We describe the emergence of a protein domain that confers th
41 In this Review
we describe the epidemiology, clinical features, course, and
42 Here,
we describe the extent of resistance of E. dermatitidis to ac
43 Herein,
we describe the mechanisms and consequences of TLR-mediated s
44 We describe the partial cranium and skeleton of a new diproto
45 Here
we describe the production of a range of mini-spidroins with
46 Here,
we describe the two-phase process by which antigen drives the
47 Here,
we describe the UBPs developed by three research teams and th
48 Here
we describe the use of discarded wound dressings as a novel,
49 In this report,
we describe the utility of one of these enzymes, Nepenthesin
50 We described the overall uptake of telemonitoring and uptake